Global Neuromodulation Devices and Implantable Infusion Pumps Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Global Neuromodulation Devices and Implantable Infusion Pumps Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Report Code: KNJ1117374 | No. of Pages: 128 | Category: Medical Devices
Publisher: GRD Survey | Date of Publish: Jan-2022
Executive Summary

According to GRD Survey data, the global Neuromodulation Devices and Implantable Infusion Pumps market is estimated at  million US$ in 2021 and is expected to reach  million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Neuromodulation Devices and Implantable Infusion Pumps market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Neuromodulation Devices and Implantable Infusion Pumps in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Spinal Cord Stimulation

    Deep Brain Stimulation

    Sacral Nerve Stimulation

    Vagal Nerve Stimulation

    Gastric Stimulation

    Transcranial Magnetic Stimulation

    Transcutaneous Electrical Stimulation

    Other

Market Snapshot, By Application
    Parkinson's Disease

    Epilepsy

    Pain

    Other

Main Market Players Analyzed in this report, including:
    Synapse Biomedical

    St. Jude Medical

    Nevro Corporation

    Neuropace

    Medtronic

    Greatbatch Medical

    Cyberonics

    Boston Scientific Corporation

    Avery Biomedical

    Autonomic Technologies


The study objectives of this report are:
    To study and analyze the global Neuromodulation Devices and Implantable Infusion Pumps market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Neuromodulation Devices and Implantable Infusion Pumps market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Neuromodulation Devices and Implantable Infusion Pumps manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Neuromodulation Devices and Implantable Infusion Pumps market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Neuromodulation Devices and Implantable Infusion Pumps submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Neuromodulation Devices and Implantable Infusion Pumps are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Neuromodulation Devices and Implantable Infusion Pumps Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Neuromodulation Devices and Implantable Infusion Pumps

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Neuromodulation Devices and Implantable Infusion Pumps Sales Channel and Distributors Analysis
        3.3.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channel
        3.3.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Parkinson's Disease

        3.4.2 Major Buyers in Epilepsy

    3.5 Neuromodulation Devices and Implantable Infusion Pumps Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Neuromodulation Devices and Implantable Infusion Pumps Type Introduction
        4.1.1 Spinal Cord Stimulation

        4.1.2 Deep Brain Stimulation

        4.1.3 Sacral Nerve Stimulation

        4.1.4 Vagal Nerve Stimulation

        4.1.5 Gastric Stimulation

        4.1.6 Transcranial Magnetic Stimulation

        4.1.7 Transcutaneous Electrical Stimulation

        4.1.8 Other
    4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type 2016-2021
    4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type 2016-2021
    4.4 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Neuromodulation Devices and Implantable Infusion Pumps Type Introduction
        5.1.1 Parkinson's Disease

        5.1.2 Epilepsy

        5.1.3 Pain

        5.1.3 Other
    5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application 2016-2021
    5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application 2016-2021
    5.4 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market by Region
        6.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Regions
        6.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Regions
    6.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market 2016-2021
    6.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market 2016-2021
    6.4 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market 2016-2021
    6.5 South America Neuromodulation Devices and Implantable Infusion Pumps Market 2016-2021
    6.6 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market 2016-2021

7 North America
    7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market by Country 2016-2021
        7.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
        7.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market by Country 2016-2021
        8.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
        8.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market by Country 2016-2021
        9.1.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
        9.1.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Market by Country 2016-2021
        10.1.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
        10.1.2 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market by Country 2016-2021
        11.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country
        11.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Synapse Biomedical

        12.1.1 Synapse Biomedical
 Company Information
        12.1.2 Synapse Biomedical
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.1.3 Synapse Biomedical
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Synapse Biomedical
 Key Development
    12.2 St. Jude Medical

        12.2.1 St. Jude Medical
 Company Information
        12.2.2 St. Jude Medical
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.2.3 St. Jude Medical
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 St. Jude Medical
 Key Development
    12.3 Nevro Corporation

        12.3.1 Nevro Corporation
 Company Information
        12.3.2 Nevro Corporation
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.3.3 Nevro Corporation
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Nevro Corporation
 Key Development
    12.4 Neuropace

        12.4.1 Neuropace
 Company Information
        12.4.2 Neuropace
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.4.3 Neuropace
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Neuropace
 Key Development
    12.5 Medtronic

        12.5.1 Medtronic
 Company Information
        12.5.2 Medtronic
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.5.3 Medtronic
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Medtronic
 Key Development
    12.6 Greatbatch Medical

        12.6.1 Greatbatch Medical
 Company Information
        12.6.2 Greatbatch Medical
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.6.3 Greatbatch Medical
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.6.4 Greatbatch Medical
 Key Development
    12.7 Cyberonics

        12.7.1 Cyberonics
 Company Information
        12.7.2 Cyberonics
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.7.3 Cyberonics
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.7.4 Greatbatch Medical
 Key Development
    12.9 Avery Biomedical

        12.9.1 Avery Biomedical
 Company Information
        12.9.2 Avery Biomedical
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.9.3 Avery Biomedical
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.9.4 Avery Biomedical
 Key Development
    12.8 Boston Scientific Corporation

        12.8.1 Boston Scientific Corporation
 Company Information
        12.8.2 Boston Scientific Corporation
 Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio, Specification and Application
        12.8.3 Boston Scientific Corporation
 Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2019-2021)
        12.8.4 Boston Scientific Corporation
 Key Development

13 Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Region by Type and by Application
    13.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue Forecast 2022-2027
    13.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Regions
        13.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Region 2022-2027
        13.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Region 2022-2027
    13.3 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Type
        13.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type 2022-2027
        13.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Type 2022-2027
        13.3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type 2022-2027
    13.4 Global Neuromodulation Devices and Implantable Infusion Pumps Forecast by Application
        13.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application 2022-2027
        13.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Forecast by Application 2022-2027
        13.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com